sEVs also modulate lipid metabolism in cancer by upregulating X-inactive specific transcript (XIST), which suppresses miR-655 and activates downstream signaling pathways that increase ATP citrate lyase (ACLY) expression. The gene discussed is PSMB5; the disease is cancer.